Nitrofurantoin inhibition of mouse liver mitochondrial respiration involving NAD-linked substrates

Insights

Nitrofurantoin (NF) and nitrofurazone (NZ) disrupt mouse liver mitochondrial respiration, primarily targeting Complex I. This toxicity may stem from reactive oxygen species generated by NF redox cycling.

Area of Science:

  • Biochemistry
  • Mitochondrial Physiology
  • Toxicology

Background:

  • Nitrofurantoin (NF) and nitrofurazone (NZ) are antimicrobial agents.
  • Their effects on cellular respiration, particularly mitochondrial function, are not fully elucidated.
  • Understanding their toxic mechanisms is crucial for safe therapeutic use.

Purpose of the Study:

  • To investigate the impact of NF and NZ on isolated mouse liver mitochondria respiration.
  • To identify the specific site of action within the mitochondrial electron transport chain.
  • To explore the role of reactive oxygen species in NF-induced mitochondrial toxicity.

Main Methods:

  • Isolated mouse liver mitochondria were used to assess respiration.
  • Complex I and Complex II substrates were employed to determine the site of inhibition.
  • Mitoplasts were utilized to study the effects on different respiratory states.
  • Superoxide dismutase and catalase were added to investigate the role of reactive oxygen species.

Main Results:

  • NF and NZ significantly inhibited mitochondrial respiration, while other nitroaromatic compounds did not.
  • The primary target of NF was Complex I (NADH-ubiquinone oxidoreductase), evidenced by decreased respiration with Complex I substrates.
  • NF inhibited both state 3 and state 4 respiration, an effect mitigated by antioxidants, suggesting reactive oxygen species involvement.

Conclusions:

  • Mitochondria, specifically Complex I of the electron transport chain, are a key target for nitrofurantoin toxicity.
  • NF-induced mitochondrial dysfunction may involve redox cycling and the generation of reactive oxygen intermediates.
  • These findings provide insights into the cellular mechanisms underlying nitrofurantoin's adverse effects.